Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective Chart Review to Evaluate the Safety Profile of Ceftobiprole in Patients With Impaired Hepatic or Renal Function or Immunosuppression

NCT04170309 is registered in ClinicalTrials.gov with Advanz Pharma as lead sponsor.

NCT NCT04170309
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04170309 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective Chart Review to Evaluate the Safety Profile of Ceftobiprole in Patients With Impaired Hepatic or Renal Function or Immunosuppression
Lead sponsor
Advanz Pharma
Phase
Observational
Overall status
Completed
Start date
March 30, 2020
Completion date
June 9, 2023
Enrollment
428 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

hepatic insufficiency, immunosuppression, renal insufficiency